Posts by: Alberto Molano, PhD

Alberto Molano, PhD

Alberto Molano was born in Bogotá, Colombia. He studied medicine at Universidad del Rosario and obtained a Ph.D. in Immunology from Weill Cornell Graduate School of Medical Sciences in New York. He conducted research and authored or co-authored twenty publications on molecular and cellular immunology, autoimmunity, immunology of aging and parasite immunology.

July 19, 2019July 19, 2019

Australian Researcher Awarded $100K to Study Non-invasive Ventilation for Sleep-disordered COPD Patients

News

Australian researcher David Geoffrey Chapman has been awarded $100,000 by the American Thoracic Society (ATS) Foundation and ResMed to investigate how non-invasive ventilation can help improve sleep patterns in ... Read more

June 7, 2019June 7, 2019

Georgia Hospital Using Zephyr Valve System to Treat Breathing Problems Due to Emphysema

News

Piedmont Atlanta announced that it is the first hospital in the state of Georgia to offer treatment for emphysema with the Zephyr Valve System, a minimally invasive therapy for ... Read more

May 24, 2019May 24, 2019

Azithromycin May Reduce Treatment Failure After COPD Exacerbations

News

Azithromycin treatment initiated during hospitalization for an acute exacerbation of chronic obstructive pulmonary disease (COPD), followed by three months of a low-maintenance dose, seems to reduce treatment failure. The results ... Read more

April 23, 2019April 23, 2019

Carrot Rewards Wellness App Launches COPD Campaign

News

Canadian wellness app Carrot Rewards has announced a new campaign in collaboration with The Lung Association — Ontario and Boehringer Ingelheim (Canada) to reach chronic obstructive pulmonary disease (COPD) patients ... Read more

April 2, 2019April 2, 2019

Circassia’s Duaklir Approved by FDA for Maintenance Treatment of COPD

News

Circassia announced that the U.S. Food and Drug Administration (FDA) approved its medication Duaklir for the maintenance treatment of chronic obstructive pulmonary disease (COPD). The company plans to launch ... Read more

March 26, 2019March 26, 2019

Novel Non-invasive Imaging Technique May Help Detect Lung Changes Earlier in COPD Patients, Study Says

News

A relatively new non-invasive imaging technique, called parametric response mapping (PRM), can identify damage in the smallest airways, opening the possibility of detecting specific lung changes earlier (when it ... Read more

February 12, 2019February 12, 2019

Nuvaira Secures $79 Million to Study Minimally Invasive COPD Treatment

News

Nuvaira, a medical device company, announced it has secured $79 million to support the AIRFLOW-3 clinical trial to assess the company’s new targeted lung denervation (TLD) system, a minimally invasive ... Read more

January 4, 2019January 4, 2019

Endobronchial Valve System Now Approved in US for Treatment of Severe Emphysema

News

The U.S. Food and Drug Administration has approved Olympus‘ Spiration Valve System (SVS) as a minimally invasive treatment for severe emphysema, a progressive form of chronic obstructive pulmonary disease (COPD). ... Read more

December 11, 2018December 11, 2018

Obesity Strongly Linked to COPD in Individuals Who Never Smoked, Study Reports

News

Chronic obstructive pulmonary disease (COPD) is much more common in obese individuals ages 50 and older who have never smoked, according to a study that also shows that the ... Read more